Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner

European Journal of Neuroscience

Volumn 19, Issue 9, 2004, Pages 2539-2550

  Etherington, Lori An V ^a   Frenguelli, Bruno G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

A1; A2A; A3; PKC; Postictal depression; Seizure

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A1 RECEPTOR ANTAGONIST; PROTEIN KINASE C; PURINE NUCLEOSIDE; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; EPILEPTIC DISCHARGE; FEMALE; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RAT; RECEPTOR INTRINSIC ACTIVITY; REDUCTION; SEIZURE; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; ANIMALS, NEWBORN; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; INDOLES; MALEIMIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; SEIZURES; THEOPHYLLINE; TIME FACTORS; TRIAZINES; TRIAZOLES;

EID: 2442532969     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-816X.2004.03355.x     Document Type: Article

References (79)

1. 3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders. Ann. N.Y. Acad. Sci., 825, 11-22.
2. 2A knockout mice. Stroke, 34, 739-744.
3. h in the timing of interictal bursts in the neonatal hippocampus. J. Neurosci., 23, 3658-3668.
4. Anderson, W.W. (1996) Epileptogenesis. In Fazeli, M.S. & Collingridge, G.L. (Eds), Cortical Plasticity: LTP and LTD. Bios Scientific Publishers, Oxford, pp. 149-189.
5. Anderson, W.W. & Collingridge, G.L. (2001) The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Meth., 108, 71-83.
6. Anderson, W.W., Lewis, D.V., Swartzwelder, H.S. & Wilson, W.A. (1986) Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res., 398, 215-219.
7. Barr, D.S., Hoyt, K.L., Moore, S.D. & Wilson, W.A. (1997) Post-ictal depression transiently inhibits induction of LTP in area CA1 of the rat hippocampal slice. Epilepsy Res., 27, 111-118.
8. 1 receptor inhibition of glutamate exocytosis and protein kinase C-mediated decoupling. J. Neurochem., 60, 1081-1086.
9. Boison, D., Huber, A., Padrun, V., Deglon, N., Aebischer, P. & Mohler, H. (2002) Seizure suppression by adenosine-releasing cells is independent of seizure frequency. Epilepsia, 43, 788-796.
10. Boison, D., Scheurer, L., Tseng, J.L., Aebischer, P. & Mohler, H. (1999) Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer. Exp. Neurol., 160, 164-174.
11. Brundege, J.M. & Dunwiddie, T.V. (1997) Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv. Pharmacol., 39, 353-391.
12. Buckmaster, P.S. & Wong, E.H. (2002) Evoked responses of the dentate gyrus during seizures in developing gerbils with inherited epilepsy. J. Neurophysiol., 88, 783-793.
13. Capogna, M., Gahwiler, B.H. & Thompson, S.M. (1996) Presynaptic inhibition of calcium-dependent and -independent release elicited with ionomycin, gadolinium, and alpha-latrotoxin in the hippocampus. J. Neurophysiol., 75, 2017-2028.
14. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci., 19, 9192-9200.
15. Coan, E.J. & Collingridge, G.L. (1985) Magnesium ions block an N-methyl-D-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci. Lett., 53, 21-26.
16. 3 receptors: modulation of synaptic plasticity in the rat hippocampus. Neurosci. Lett., 302, 53-57.
17. Cunha, R.A., Correia-de-Sa, P., Sebastiao, A.M. & Ribeiro, J.A. (1996) Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br. J. Pharmacol., 119, 253-260.
18. Dale, N., Pearson, T. & Frenguelli, B.G. (2000) Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J. Physiol. (Lond.), 526, 143-155.
19. De Sarro, G., De Sarro, A., Di Paola, E.D. & Bertorelli, R. (1999) Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur. J. Pharmacol., 371, 137-145.
20. Dixon, A.K., Gubitz, A.K., Sirinathsinghji, D.J., Richardson, P.J. & Freeman, T.C. (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol., 118, 1461-1468.
21. Dunwiddie, T.V. (1980) Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia, 21, 541-548.
22. Dunwiddie, T.V. (1999) Adenosine and suppression of seizures. Adv. Neurol., 79, 1001-1010.
23. 1 receptor-mediated responses in rat hippocampus. J. Neurosci., 17, 607-614.
24. 3 receptor-selective agonist does not modulate calcium-activated potassium currents in hippocampal CA1 pyramidal neurons. Prog. Brain Res., 120, 275-285.
25. Dunwiddie, T.V. & Masino, S.A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 24, 31-55.
26. During, M.J. & Spencer, D.D. (1992) Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol., 32, 618-624.
27. [3H]SCH 58261. Eur. J. Neurosci., 14, 1567-1570.
28. Eldridge, F.L., Paydarfar, D., Scott, S.C. & Dowell, R.T. (1989) Role of endogenous adenosine in recurrent generalized seizures. Exp. Neurol., 103, 179-185.
29. 3 receptors potentiate hippocampal calcium current by a PKA-dependent/PKC-independent pathway. Neuropharmacology, 36, 353-362.
30. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Klotz, K.N. & Linden, J. (2001a) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 53, 527-552.
31. Fredholm, B.B., Irenius, E., Kull, B. & Schulte, G. (2001b) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol., 61, 443-448.
32. 1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia, 44, 877-885.
33. Gouder, N., Scheurer, L., Fritschy, J.M. & Boison, D. (2004) Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J. Neurosci., 24, 692-701.
34. Haas, H.L. & Selbach, O. (2000) Functions of neuronal adenosine receptors. Naunyn Schmiedebergs Arch. Pharmacol., 362, 375-381.
35. 1 receptor binding reduces hypoxic-ischemic brain injury in newborn rats. Brain Res., 759, 309-312.
36. 2A receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci. Lett., 329, 289-292.
37. Huber, A., Padrun, V., Deglon, N., Aebischer, P., Mohler, H. & Boison, D. (2001) Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc. Natl. Acad. Sci. USA. 98, 7611-7616.
38. 3 receptors: novel ligands and paradoxical effects. Trends Pharmacol. Sci., 19, 184-191.
39. 3-adenosine receptors. Mediation of behavioral depressant effects. FEBS Lett., 336, 57-60.
40. Janusz, C.A. & Berman, R.F. (1993) The adenosine binding enhancer, PD 81,723, inhibits epileptiform bursting in the hippocampal brain slice. Brain Res., 619, 131-136.
41. 3 adenosine receptor antagonists. J. Med. Chem., 40, 2596-2608.
42. 2A receptor antagonist. Brain Res., 800, 328-335.
43. 1 agonists with diminished hypotensive effects. J. Med. Chem., 42, 3463-3477.
44. Kowaluk, E.A. & Jarvis, M.F. (2000) Therapeutic potential of adenosine kinase inhibitors. Expert. Opin. Invest. Drugs, 9, 551-564.
45. 2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br. J. Pharmacol., 128, 1035-1044.
46. 2 adenosine receptor ligands in rat hippocampal slices. Neurosci. Lett., 200, 21-24.
47. 1 receptor inhibition. Neuroscience, 112, 319-329.
48. 3 receptors are located in neurons of the rat hippocampus. Neuroreport, 14, 1645-1648.
49. 3 receptor stimulation on seizures in mice. Eur. J. Pharmacol., 275, 23-29.
50. 3 receptors in cerebral ischemia. Neuronal death, recovery, or both? Ann. N.Y. Acad. Sci., 890, 93-106.
51. 3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. J. Neurosci., 18, 6138-6146.
52. Mager, R., Ferroni, S. & Schubert, P. (1990) Adenosine modulates a voltage-dependent chloride conductance in cultured hippocampal neurons. Brain Res., 532, 58-62.
53. Malhotra, J. & Gupta, Y.K. (1997) Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Br. J. Pharmacol., 120, 282-288.
54. 2+ of NMDA responses in spinal cord neurones. Nature, 309, 261-263.
55. 1 receptor activation. Neuroreport, 6, 1097-1100.
56. de Mendonça, A., Sebastiao, A.M. & Ribeiro, J.A. (2000) Adenosine: does it have a neuroprotective role after all? Brain Res. Brain Res. Rev., 33, 258-274.
57. Meno, J.R., Higashi, H., Cambray, A.J., Zhou, J., D'Ambrosio, R. & Winn, H.R. (2003) Hippocampal injury and neurobehavioral deficits are improved by PD 81,723 followinghyperglycemiccerebral ischemia. Exp. Neurol., 183, 188-196.
58. Nowak, L., Bregestovski, P., Ascher, P., Herbet, A. & Prochiantz, A. (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature, 307, 462-465.
59. 2 receptor-mediated responses in the rat hippocampus in vitro. Eur. J. Pharmacol., 362, 17-25.
60. Pan, H.L., Xu, Z., Leung, E. & Eisenach, J.C. (2001) Allosteric adenosine modulation to reduce allodynia. Anesthesiology, 95, 416-420.
61. Pearson, T., Nuritova, F., Caldwell, D., Dale, N. & Frenguelli, B.G. (2001) A depletable pool of adenosine in area CA1 of the rat hippocampus. J. Neurosci., 21, 2298-2307.
62. 2+ in membrane excitability? Neuroreport, 14, 659-668.
63. 2a selective adenosine receptor antagonist. Br. J. Pharmacol., 115, 1096-1102.
64. 2+ in intact immature brain structures. Eur. J. Neurosci., 16, 850-860.
65. 1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur. J. Neurosci., 18, 820-828.
66. 1 receptors in nerve terminals and synapses of the rat hippocampus. Brain Res., 987, 49-58.
67. 2A receptor facilitation of synaptic transmission in the hippocampus of aged rats. J. Neurophysiol., 90, 1295-1303.
68. 1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res., 677, 193-203.
69. Scholz, K.P. & Miller, R.J. (1992) Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses. Neuron, 8, 1139-1150.
70. Schwechter, E.M., Vehskova, J. & Velisek, L. (2003) Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann. Neurol., 53, 91-101.
71. Sebastiao, A.M. & Ribeiro, J.A. (2000) Fine-tuning neuromodulation by adenosine. Trends Pharmacol. Sci., 21, 341-346.
72. 1 receptor-mediated mechanisms in the juvenile rat hippocampus. J. Pharmacol. Exp. Ther., 286, 1412-1419.
73. Tancredi, V., Hwa, G.G., Zona, C., Brancati, A. & Avoli, M. (1990) Low magnesium epileptogenesis in the rat hippocampal slice: electrophysiological and pharmacological features. Brain Res., 511, 280-290.
74. Wiesner, J.B., Ugarkar, B.G., Castellino, A.J., Barankiewicz, J., Dumas, D.P., Gruber, H.E., Foster, A.C. & Erion, M.D. (1999) Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J. Pharmacol. Exp. Ther., 289, 1669-1677.
75. Wu, L.G. & Saggau, P. (1994) Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron, 12, 1139-1148.
76. Yoon, K.W. & Rothman, S.M. (1991) Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. J. Neurosci., 11, 1375-1380.
77. Young, D. & Dragunow, M. (1994) Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience, 58, 245-261.
78. 1 receptors underlies anticonvulsant effect of CGS21680. Eur. J. Pharmacol., 255, 239-243.
79. Zhang, J.M., Wang, H.K., Ye, C.Q., Ge, W., Chen, Y., Jiang, Z.L., Wu, C.P., Poo, M.M. & Duan, S. (2003) ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron, 40, 971-982.